Unknown PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT01317992

Ibudilast in the Treatment of Medication Overuse Headache

Ibudilast in the Treatment of Medication Overuse Headache: A Double-blind, Randomised, Placebo-controlled Pilot Study

Sponsor: University of Adelaide

Updated 5 times since 2017 Last updated: Feb 4, 2013 Started: Apr 30, 2011 Primary completion: Jun 30, 2013 Completion: Aug 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01317992, this PHASE1/PHASE2 trial focuses on Medication Overuse Headache and remains ongoing. Sponsored by University of Adelaide, it has been updated 5 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1/PHASE2

Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE1_PHASE2

First recorded

Apr 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Adelaide
University of South Australia

Data source: University of Adelaide

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Adelaide, Australia